Astellas, Boehringer, Ranbaxy Resolve Flomax Spat
A judge has dismissed a patent suit that Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals Inc. lodged against Ranbaxy Laboratories Ltd. over the enlarged prostate treatment Flomax, and vacated the court's...To view the full article, register now.
Already a subscriber? Click here to view full article